Cargando…
Peak plasma concentration of direct oral anticoagulants in obese patients weighing over 120 kilograms: A retrospective study
BACKGROUND: Due to a paucity of data on the efficacy and safety of direct oral anticoagulants (DOACs) in patients with a body mass index >40 kg/m(2) or a weight >120 kg, the use of DOACs in this group is not recommended. OBJECTIVES: To determine the proportion of obese patients with body weigh...
Autores principales: | Piran, Siavash, Traquair, Hugh, Chan, Noel, Bhagirath, Vinai, Schulman, Sam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6178753/ https://www.ncbi.nlm.nih.gov/pubmed/30349887 http://dx.doi.org/10.1002/rth2.12146 |
Ejemplares similares
-
Outcomes in patients undergoing periprocedural interruption of warfarin or direct oral anticoagulants
por: Lee, Jeffrey, et al.
Publicado: (2022) -
Carbamazepine, phenytoin, and oral anticoagulants: Drug‐drug interaction and clinical events in a retrospective cohort
por: Candeloro, Matteo, et al.
Publicado: (2022) -
Anticoagulant therapy for splanchnic vein thrombosis: an individual patient data meta-analysis
por: Candeloro, Matteo, et al.
Publicado: (2022) -
Defective fibrin deposition and thrombus stability in Bambi
(−/−) mice are mediated by elevated anticoagulant function
por: Crawley, James T. B., et al.
Publicado: (2019) -
Switching from vitamin K antagonists to direct oral anticoagulants: Treatment satisfaction and patient concerns
por: Toorop, Myrthe M. A., et al.
Publicado: (2020)